Established 1999
     
8,000 companies from USA and India.  
   
Search over 25,500 news articles and 8,000 companies earnings    


Pfizer Inc (PFE)
$21.48 -0.15 (-0.69%)   Jan 27

235 East 42nd Street , New York,  NY  10017-5755 , USA
+1-212-573-2323
  http://www.pfizer.com
PRICES
VALUATIONS
RATIOS
STOCKHOLDERS
Open
Volume
Mkt Cap

P/E
EPS (prev. yr)
Dividend
Yield
21.60
132.87M
172054

n/a
n/a
0.80
3.72%
High
Low
52wk    High
52wk
Low
BV
P/BV
Outstanding Shares

21.60
21.45
21.99
16.66
10.94
1.96
8009.95

You need to upgrade your Flash Player
Chart Type: Line - Basic Comparison OHLC Candlestick Smooth


amcolumn
You need to upgrade your Flash Player


You need to upgrade your Flash Player

Financial Summary (In millions of USD)
2003
2004
2005
2006
2007
2008
2009
2010
Income Statement
Total Revenue
$44,736
$48,988
$47,405
$48,371
$48,418
$48,296
$50,009
$67,809
Operating Income
$3,246
$13,403
$10,800
$13,028
$9,278
$9,694
$10,827
$9,422
Net Income
$3,910
$11,361
$8,085
$19,337
$8,144
$8,104
$8,635
$8,257
Balance Sheet
Total Assets
$116,775
$123,078
$116,970
$114,837
$115,268
$111,148
$111,148
$212,949
Total Equity
$65,377
$68,278
$65,764
$71,358
$65,010
$57,556
$57,556
$90,014
Total Liabilities
$51,398
$54,800
$51,206
$43,479
$50,258
$53,592
$53,592
$122,935
Cash Flow
Operating
$11,727
$16,340
$14,733
$17,594
$13,353
$18,238
$18,238
$16,587
Investing
$4,850
$-9,422
$-5,072
$5,101
$795
$-12,835
$-12,835
$-31,272
Financing
$-16,909
$-6,629
$-9,222
$-23,100
$-12,610
$-6,560
$-6,560
$14,481
Net Cash Change
$-358
$288
$439
$-420
$1,579
$-1,284
$-1,284
$-144

Earnings Calls Calendar
2010
2009
2008
2007
2006
03 February 2010
04 May 2010
03 August 2010
02 November 2010
28 January 2009
28 April 2009
22 July 2009
20 October 2009
23 January 2008
17 April 2008
23 July 2008
21 October 2008
20 April 2007
18 July 2007
18 October 2007
19 January 2006
19 April 2006
20 July 2006

Earnings Calls Summary
 Transcripts
03 February 2009 7:17 AM
18 Septempber 2010 10:23 AM
28 July 2008 11:07 AM
09 February 2010 12:22 AM
04 June 2008 11:07 AM
03 March 2008 10:25 AM
18 January 2008 4:30 AM
23 October 2007 2:12 PM
25 April 2006 9:53 AM

10K Reports
 Annual Reports

123Jump News
04 April 2011 1:00 PM
Google, King Pharma, ActivIdentity Rise; Global Payments Fall
12 October 2010 12:58 PM
Pfizer Q2 Earnings Call Transcript
18 Septempber 2010 10:19 AM
Pfizer Q4 2009 Earnings Call Transcript
09 February 2010 12:22 AM
U.S. Extends World Rally; Treasury Auction
09 November 2009 6:53 PM
Global Markets Decline; Brazil, Canada Lead
28 October 2009 9:26 PM
U.S. Stocks Fall on Housing Data; Apple Up
20 October 2009 4:51 PM
Earnings Euphoria; Goldman Warrants $1.1 B
22 July 2009 5:15 PM
GDP Declines 6.1%; Bank of America Rises
29 April 2009 10:42 AM
Freeport McMoran Rises; Caterpillar Plunges
26 January 2009 3:59 PM
More...

Management
Executive
Title
Jeffrey B. Kindler
Chief Executive Officer and Chairman of the Board
Frank DAmelio
Chief Financial Officer
Martin Mackay
President, Pfizer Global Research & Development
Joe Feczko
Chief Medical Officer
Corey Goodman
President, Biotherapeutics and Bioinnovation Center
Ian Read
President,Worldwide Pharmaceutical Operations
Natale S. Ricciardi
President/Team Leader, Pfizer Global Manufacturing Senior Vice President
Rich Bagger
Senior Vice President, Worldwide Public Affairs and Policy
Mary S. McLeod
Senior Vice President, Worldwide Human Resources
Sally Susman
Senior Vice President & Chief Communications Officer


Sources: Data collected by 123jump.com and Ticker.com from company press releases, filings and corporate websites.
Market data: BATS Exchange. Inc.
350 Fund Managers Interviews - 10-year Annual earnings on 4,600 U.S. companies - 20-quarter Earnings on 3,800 U.S. companies - 3,200 U.S. IPO Prospectuses
- 2,100 Economic data releases from U.S., EU, UK, India, HK and Australia. 10-year Annual reports on 3,500 U.S. companies -
U.S. Earnings Calendar with 4,800 companies - 90,000 10-K reports - 26,000 Global markets news archive - 2,200 Earnings Conference Call Summaries
Other Sites:
© 1999-2012 123jump.com. All rights reserved